Kaicheng Li

机构：Shanghai CASB Biotechnology (China), Center for Excellence in Brain Science and Intelligence Technology, Shanghai Xuhui Central Hospital, Second Affiliated Hospital of Zhejiang University, Viva Biotech (China) · ORCID：0000-0001-7732-3076

发表论文 66 篇 · 总被引 2076 次 · h-index 22

代表论文

• Lysine-Targeted Reversible Covalent Ligand Discovery for Proteins via Phage Display (2022 · Journal of the American Chemical Society · 被引 72)
• A genome-wide atlas of antibiotic susceptibility targets and pathways to tolerance (2022 · Nature Communications · 被引 47)
• Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice (2022 · Neurotherapeutics · 被引 21)
• Modeling disrupted synapse formation in wolfram syndrome using hESCs-derived neural cells and cerebral organoids identifies Riluzole as a therapeutic molecule (2023 · Molecular Psychiatry · 被引 19)
• Psychotic Symptom, Mood, and Cognition-associated Multimodal MRI Reveal Shared Links to the Salience Network Within the Psychosis Spectrum Disorders (2022 · Schizophrenia Bulletin · 被引 19)
• Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer’s Disease Continuum (2023 · Journal of Alzheimer s Disease · 被引 17)